Johnson & Johnson
JNJ: XNYS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$869.00 | Xdyf | Rfkkwzxr |
J&J's Diversified Pharma and Device Businesses Support a Solid Wide Moat
Business Strategy and Outlook
Johnson & Johnson stands alone as a leader across the major healthcare industries. It maintains a diverse revenue base, a developing research pipeline, and exceptional cash flow generation that together create a wide economic moat.